NTRP - Neurotrope, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development4,885.5634,763.4546,632.9044,203.858
Selling General and Administrative4,047.2225,495.13,495.2074,518.965
Non Recurring----
Others----
Total Operating Expenses11,149.39612,701.99712,932.6389,445.757
Operating Income or Loss-11,149.396-12,701.997-12,932.638-9,445.757
Income from Continuing Operations
Total Other Income/Expenses Net127.1186.9278.4364.222
Earnings Before Interest and Taxes-11,149.396-12,701.997-12,932.638-9,445.757
Interest Expense----
Income Before Tax-11,022.286-12,615.07-12,924.202-9,441.535
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-11,022.286-12,615.07-12,924.202-9,441.535
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-11,022.286-12,615.07-12,924.202-9,441.535
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-11,022.286-12,615.07-12,924.202-9,721.359